AU2018904604A0 - Methods and compositions for the treatment of cancer - Google Patents

Methods and compositions for the treatment of cancer

Info

Publication number
AU2018904604A0
AU2018904604A0 AU2018904604A AU2018904604A AU2018904604A0 AU 2018904604 A0 AU2018904604 A0 AU 2018904604A0 AU 2018904604 A AU2018904604 A AU 2018904604A AU 2018904604 A AU2018904604 A AU 2018904604A AU 2018904604 A0 AU2018904604 A0 AU 2018904604A0
Authority
AU
Australia
Prior art keywords
cancer
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018904604A
Inventor
Eleanor Eiffe
Peter Gunning
Edna Hardeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trobio Therapeutics Pty Ltd
Original Assignee
Trobio Therapeutics Pty Ltd
Filing date
Publication date
Application filed by Trobio Therapeutics Pty Ltd filed Critical Trobio Therapeutics Pty Ltd
Publication of AU2018904604A0 publication Critical patent/AU2018904604A0/en
Assigned to TroBio Therapeutics Pty Ltd reassignment TroBio Therapeutics Pty Ltd Request for Assignment Assignors: EIFFE, ELEANOR, GUNNING, PETER, HARDEMAN, EDNA
Abandoned legal-status Critical Current

Links

AU2018904604A 2018-12-04 Methods and compositions for the treatment of cancer Abandoned AU2018904604A0 (en)

Publications (1)

Publication Number Publication Date
AU2018904604A0 true AU2018904604A0 (en) 2018-12-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP3894392A4 (en) Compositions and methods for the treatment of cancer
EP3947715A4 (en) Methods and compositions for treating cancer
EP3490581A4 (en) Neuromodulating compositions and related therapeutic methods for the treatment of cancer
EP3716767A4 (en) Methods and compositions for the treatment of rare diseases
IL276808A (en) Compositions and methods for cancer treatment
EP3585817A4 (en) Compositions and methods for treatment of cancer
EP3826666A4 (en) Compositions and methods for treating nrp2-associated diseases
EP3775263A4 (en) Compositions and methods for the treatment of acne
EP3478284A4 (en) Compounds and compositions for the treatment of cancer
EP4055040A4 (en) Compositions and methods for treatment of cancer with lekti
EP3688023A4 (en) Methods and compositions for cancer treatment
EP3452044A4 (en) Compositions and methods for the treatment of cancer
EP3820492A4 (en) Apmv and uses thereof for the treatment of cancer
EP3773585A4 (en) Compositions and methods for treating cancer
EP3793544A4 (en) Bifunctional compositions for the treatment of cancer
EP4051260A4 (en) Methods and compositions for treatment of cancer
EP3568020A4 (en) Compositions and methods for the treatment of demyelinating conditions
IL272147A (en) Methods and compositions for the treatment of cancer
EP3681498A4 (en) Methods and compositions for the treatment of cancer
EP3826623A4 (en) Compositions and methods for the treatment of cancer characterized with pcsk9 expression
EP3762035A4 (en) Compositions and methods for the diagnosis and treatment of alt cancer
EP3911358A4 (en) Methods and compositions for treatment of cancer
EP3515431A4 (en) Compositions and methods for treatment of cancer
EP3987032A4 (en) Methods and compositions for the treatment of cancer
IL280262A (en) Compositions and methods for the treatment of cancer